PRLD
Prelude Therapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$4.87
+6.56%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+9.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2026 | Dorton Katina · director | A-Award | 38,000 | $3.94 |
| Jun 10, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | A-Award | 38,000 | $3.94 |
| Jun 10, 2026 | FRIEDMAN PAUL A · director | A-Award | 38,000 | $3.94 |
| Jun 10, 2026 | Sandor Victor · director | A-Award | 38,000 | $3.94 |
| Jun 10, 2026 | Bonita David P · director, 10 percent owner: | A-Award | 38,000 | $3.94 |
| Jun 10, 2026 | Babler Martin · director | A-Award | 38,000 | $3.94 |
| May 4, 2026 | Morris Charles Q · officer: Chief Medical Officer | A-Award | 450,000 | $4.70 |
| Apr 23, 2026 | ORBIMED ADVISORS LLC · director, 10 percent owner: | Purchase | 1,689,189 | $4.44 |
| Apr 23, 2026 | ORBIMED ADVISORS LLC · director, 10 percent owner: | Purchase | 1,126,126 | $4.44 |
| Apr 23, 2026 | Bonita David P · director, 10 percent owner: | Purchase | 1,689,189 | $4.44 |
| Apr 23, 2026 | Bonita David P · director, 10 percent owner: | Purchase | 1,126,126 | $4.44 |
| Apr 22, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | Purchase | 114,601 | $0.00 |
| Apr 22, 2026 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | Purchase | 2,137,651 | $0.00 |
| Feb 5, 2026 | Lim Bryant David · officer: CLO, CFO, Corp Sec. | A-Award | 275,000 | $2.30 |
| Feb 5, 2026 | Combs Andrew · officer: Chief Chemistry Officer | A-Award | 230,000 | $2.30 |
| Feb 5, 2026 | Vaddi Krishna · director, officer: CEO | A-Award | 837,000 | $2.30 |
| Feb 5, 2026 | Scherle Peggy · officer: Chief Scientific Officer | A-Award | 230,000 | $2.30 |
| Nov 7, 2025 | Sandor Victor · director | A-Award | 121,285 | $1.39 |
| Oct 7, 2025 | Huang Jane · officer: President, CMO | M-Exempt | 9,375 | $0.00 |
| Oct 7, 2025 | Huang Jane · officer: President, CMO | F-InKind | 3,355 | $1.47 |
| Jul 8, 2025 | Huang Jane · officer: President, CMO | F-InKind | 3,355 | $0.79 |
| Jul 8, 2025 | Huang Jane · officer: President, CMO | M-Exempt | 9,375 | $0.00 |
| Jun 13, 2025 | Sandor Victor · director | A-Award | 38,000 | $1.04 |
| Jun 13, 2025 | BAKER BROS. ADVISORS LP · director, 10 percent owner: | A-Award | 76,000 | $1.04 |
| Jun 13, 2025 | Dier Mardi · director | A-Award | 38,000 | $1.04 |
| Jun 13, 2025 | FRIEDMAN PAUL A · director | A-Award | 38,000 | $1.04 |
| Jun 13, 2025 | Bonita David P · director, 10 percent owner: | A-Award | 38,000 | $1.04 |
| Jun 13, 2025 | Babler Martin · director | A-Award | 38,000 | $1.04 |
| Apr 7, 2025 | Huang Jane · officer: President, CMO | F-InKind | 3,355 | $0.68 |
| Apr 7, 2025 | Huang Jane · officer: President, CMO | M-Exempt | 9,375 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 47Increased 46Reduced 22Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ORBIMED ADVISORS LLC | Increased | 13,724,571 | Aug 14, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 10,909,256 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 10,123,824 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 10,123,824 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | New Position | 6,475,882 | Aug 14, 2026 |
| Soleus Capital Management, L.P. | New Position | 3,378,378 | Aug 11, 2026 |
| Kynam Capital Management, LP | Increased | 2,415,087 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,009,445 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 1,797,501 | Aug 7, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Increased | 1,592,551 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,230,406 | May 15, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | Increased | 1,019,832 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 993,369 | Aug 14, 2026 |
| ECOR1 CAPITAL, LLC | New Position | 947,049 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 923,626 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2026